Advanced Biomed (ADVB) said Friday it has raised about $6.6 million from the initial public offering of 1.6 million shares at $4.00 per share.
The biotechnology company said it has granted its underwriter a 45-day option to buy up to 246,000 additional shares. Craft Capital Management acted as underwriter for the offering.
The shares started trading on Nasdaq Thursday.
Price: 3.67, Change: +0.02, Percent Change: +0.66
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.